Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.11), $0.03 better than ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE